Your session is about to expire
← Back to Search
PCIP for Post-Traumatic Stress Disorder (APCIP Trial)
APCIP Trial Summary
This trial will help assess whether the Primary Care Intervention for PTSD is an effective and sustainable treatment option for PTSD patients.
APCIP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowAPCIP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.APCIP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can complete study activities in English.I can give consent and complete procedures in English.My guardian can consent for me as I am under 18.I am at least 12 years old.I have not had thoughts of suicide with a plan in the last 2 weeks or attempted suicide in the last 30 days.
- Group 1: Treatment As Usual
- Group 2: BREATHE Primary Care Intervention for PTSD (PCIP)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the aggregate amount of participants in this experiment?
"Affirmative. The information provided on clinicaltrials.gov demonstrates that this experiment, which was initially published on 3rd January 2022, is still recruiting participants. 45 volunteers are required from a single medical facility to participate in the trial."
What are the key objectives of this clinical trial?
"The primary aim of this trial is to measure the transformation in trauma-associated cognitions over a 10 month period from baseline. Secondary objectives are focused on alterations in adverse childhood experiences using PEARLS, shifts in trauma symptoms via the CPSS-5-SR Self Report, and transformations in PTSD related signs with UCLA Child/Adolescent PTSD Reaction Index for DSM-5 Brief Screen."
Who is validated to participate in this clinical experiment?
"To qualify for the trial, individuals should have a diagnosis of PTSD and be between 12 and 22 years old. Currently, 45 participants are needed to complete the study."
Are participants being accepted for this research project presently?
"Affirmative. Clinicaltrials.gov demonstrates that, as of February 25th 2022, this clinical trial is currently searching for 45 participants from a single location. This study was initially listed on March 1st 2022."
Are individuals aged 35 and older eligible to participate in this clinical experiment?
"The study requires that applicants be younger than 23 and older than 11. Per the clinical trial registry, there are 288 trials for patients under 18 years of age and 865 for those above 65."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger